David Hodgson
YOU?
Author Swipe
View article: Limited-stage Mantle Cell Lymphoma: Real-world outcomes according to nodal vs. extranodal presentation
Limited-stage Mantle Cell Lymphoma: Real-world outcomes according to nodal vs. extranodal presentation Open
Introduction Mantle cell lymphoma (MCL) treatment has evolved significantly in recent years, with a paradigm shift from traditional chemotherapy-based regimens to targeted therapies and chemo-free combinations. Despite these advances, opti…
View article: Colorectal-Specific Radiation Dose and Chemotherapy Risk for Subsequent Colorectal Malignancies in Childhood Cancer Survivors: A Childhood Cancer Survivor Study (CCSS) Report
Colorectal-Specific Radiation Dose and Chemotherapy Risk for Subsequent Colorectal Malignancies in Childhood Cancer Survivors: A Childhood Cancer Survivor Study (CCSS) Report Open
PURPOSE Among childhood cancer survivors, we evaluated not previously explored relationships between colorectal subsequent malignant neoplasm (SMN) incidence and colorectum-specific radiation dose metrics currently used in radiation therap…
View article: Inferior survival in double refractory large B-cell lymphoma eligible for third-line CD19 CAR T-cell therapy
Inferior survival in double refractory large B-cell lymphoma eligible for third-line CD19 CAR T-cell therapy Open
View article: An Individualized Prediction Model for Early-Stage Classic Hodgkin’s Lymphoma
An Individualized Prediction Model for Early-Stage Classic Hodgkin’s Lymphoma Open
Utilizing objective, continuous, and readily available variables, we developed and validated a new prediction model for early-stage cHL. Male sex, lower hemoglobin or albumin levels, and higher MTDs were associated with worse PFS. (Funded …
View article: Evaluation of the Childhood Hodgkin International Prognostic Score (CHIPS) in High‐Risk Pediatric Hodgkin Lymphoma Patients Treated on Children's Oncology Group AHOD1331
Evaluation of the Childhood Hodgkin International Prognostic Score (CHIPS) in High‐Risk Pediatric Hodgkin Lymphoma Patients Treated on Children's Oncology Group AHOD1331 Open
Background CHIPS (Childhood Hodgkin International Prognostic Score), a predictive score for event‐free‐survival (EFS), was originally developed using factors presenting at diagnosis in patients with intermediate‐risk Hodgkin lymphoma (HL).…
View article: Prognostic value of early post-treatment 18F-FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T-cell therapy
Prognostic value of early post-treatment 18F-FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T-cell therapy Open
View article: 311 | OUTCOMES OF PATIENTS WITH PRIMARY REFRACTORY AND EARLY RELAPSING LARGE B CELL LYMPHOMA ARE INFERIOR IN THE CD19 CAR T CELL THERAPY ERA
311 | OUTCOMES OF PATIENTS WITH PRIMARY REFRACTORY AND EARLY RELAPSING LARGE B CELL LYMPHOMA ARE INFERIOR IN THE CD19 CAR T CELL THERAPY ERA Open
View article: 761 | SURVIVAL OUTCOMES IN NODAL PERIPHERAL T‐CELL LYMPHOMA FOLLOWING PRIMARY AND SECOND‐LINE TREATMENT: AN AUSTRALASIAN‐CANADIAN COLLABORATIVE STUDY
761 | SURVIVAL OUTCOMES IN NODAL PERIPHERAL T‐CELL LYMPHOMA FOLLOWING PRIMARY AND SECOND‐LINE TREATMENT: AN AUSTRALASIAN‐CANADIAN COLLABORATIVE STUDY Open
View article: 126 | THE EARLY‐STAGE CLASSIC HODGKIN LYMPHOMA INTERNATIONAL PROGNOSTICATION INDEX (E‐HIPI): AN INDIVIDUALIZED PREDICTION MODEL UTILIZING OBJECTIVE AND CONTINUOUS VARIABLES
126 | THE EARLY‐STAGE CLASSIC HODGKIN LYMPHOMA INTERNATIONAL PROGNOSTICATION INDEX (E‐HIPI): AN INDIVIDUALIZED PREDICTION MODEL UTILIZING OBJECTIVE AND CONTINUOUS VARIABLES Open
View article: 390 | END‐OF‐TREATMENT PET/CT COMPLETE REMISSION IS HIGHLY PROGNOSTIC IN NODAL PERIPHERAL T‐CELL LYMPHOMA: AN AUSTRALASIAN‐CANADIAN COLLABORATIVE STUDY
390 | END‐OF‐TREATMENT PET/CT COMPLETE REMISSION IS HIGHLY PROGNOSTIC IN NODAL PERIPHERAL T‐CELL LYMPHOMA: AN AUSTRALASIAN‐CANADIAN COLLABORATIVE STUDY Open
View article: 309 | IMPACT OF AGE ON TREATMENT DECISIONS AND OUTCOMES IN RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA
309 | IMPACT OF AGE ON TREATMENT DECISIONS AND OUTCOMES IN RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA Open
View article: 328 | INTENTION‐TO‐TREATMENT ANALYSIS OF THIRD LINE CAR‐T FOR RELAPSE/REFRACTORY LARGE B CELL LYMPHOMA
328 | INTENTION‐TO‐TREATMENT ANALYSIS OF THIRD LINE CAR‐T FOR RELAPSE/REFRACTORY LARGE B CELL LYMPHOMA Open
View article: 454 | ASSOCIATION OF BRIDGING THERAPY WITH RESPONSE AND OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B CELL LYMPHOMA RECEIVING THIRD LINE CAR‐T
454 | ASSOCIATION OF BRIDGING THERAPY WITH RESPONSE AND OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B CELL LYMPHOMA RECEIVING THIRD LINE CAR‐T Open
View article: 109 | ULTRA‐LOW DOSE RADIOTHERAPY (ULDR) (4Gy) FOR INDOLENT ORBITAL ADNEXAL LYMPHOMAS (IOAL): AN INTERNATIONAL LYMPHOMA RADIATION ONCOLOGY GROUP STUDY
109 | ULTRA‐LOW DOSE RADIOTHERAPY (ULDR) (4Gy) FOR INDOLENT ORBITAL ADNEXAL LYMPHOMAS (IOAL): AN INTERNATIONAL LYMPHOMA RADIATION ONCOLOGY GROUP STUDY Open
View article: 735 | OUTCOMES IN DOUBLE‐EXPOSED CLASSICAL HODGKIN LYMPHOMA: IMPACT OF TREATMENT SEQUENCE AND SALVAGE STRATEGIES AFTER BRENTUXIMAB VEDOTIN AND CHECKPOINT INHIBITOR FAILURE
735 | OUTCOMES IN DOUBLE‐EXPOSED CLASSICAL HODGKIN LYMPHOMA: IMPACT OF TREATMENT SEQUENCE AND SALVAGE STRATEGIES AFTER BRENTUXIMAB VEDOTIN AND CHECKPOINT INHIBITOR FAILURE Open
View article: 313 | DOUBLE REFRACTORY STATUS CONFIRMS INFERIOR SURVIVAL IN LARGE B‐CELL LYMPHOMA ELIGIBLE FOR THIRD‐LINE CD19 CHIMERIC ANTIGEN T‐CELL THERAPY
313 | DOUBLE REFRACTORY STATUS CONFIRMS INFERIOR SURVIVAL IN LARGE B‐CELL LYMPHOMA ELIGIBLE FOR THIRD‐LINE CD19 CHIMERIC ANTIGEN T‐CELL THERAPY Open
View article: Outcomes and factors influencing survival in patients with diffuse large B-cell lymphoma: a population-based analysis
Outcomes and factors influencing survival in patients with diffuse large B-cell lymphoma: a population-based analysis Open
Given the rapidly evolving treatment landscape for diffuse large B-cell lymphoma (DLBCL), we performed a contemporary analysis of survival outcomes in patients aged ≥18 years with DLBCL at the population level using linked administrative d…
View article: Outcomes of Primary Mediastinal B-cell Lymphoma Patients with Partial Metabolic Response: A Multicenter Retrospective Analysis
Outcomes of Primary Mediastinal B-cell Lymphoma Patients with Partial Metabolic Response: A Multicenter Retrospective Analysis Open
Patients with PMBCL often have an IMR. PMR (a DS score of 4) managed with subsequent RT is associated with excellent outcomes. SUVmax may identify patients who may require more or less intensive treatment.
View article: 18F-FDG PET or PET/CT in detecting high-grade transformation of chronic lymphocytic leukaemia and indolent lymphomas: a systematic review and meta-analysis
18F-FDG PET or PET/CT in detecting high-grade transformation of chronic lymphocytic leukaemia and indolent lymphomas: a systematic review and meta-analysis Open
Objectives To evaluate the diagnostic accuracy of 18F-FDG positron emission tomography (PET) or PET/computed tomography (CT) in detecting histological transformation (HT) of indolent lymphomas. Methods A systematic search of articles up to…
View article: The A-HIPI prediction model in advanced-stage Hodgkin lymphoma: identification of risk groups and creation of an online tool
The A-HIPI prediction model in advanced-stage Hodgkin lymphoma: identification of risk groups and creation of an online tool Open
No abstract available
View article: Integrity of Delivered Dose in Temporally Fractionated Lattice Radiotherapy Amid Anatomical Changes and Setup Uncertainties
Integrity of Delivered Dose in Temporally Fractionated Lattice Radiotherapy Amid Anatomical Changes and Setup Uncertainties Open
View article: Retrospective Review of Spinal Cord Compression Occurrences and Management in Children With Relapsed, Progressing, or Refractory Malignancies
Retrospective Review of Spinal Cord Compression Occurrences and Management in Children With Relapsed, Progressing, or Refractory Malignancies Open
Background Spinal cord compression (SCC) is a severe complication in pediatric patients with relapsed, progressing, or refractory solid malignancies. This study aims to report the presentation, treatment, and role of proactive radiation th…
View article: Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma
Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma Open
N+AVD resulted in longer progression-free survival than BV+AVD in adolescents and adults with stage III or IV advanced-stage classic Hodgkin's lymphoma and had a better side-effect profile. (Funded by the National Cancer Institute of the N…
View article: Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results Open
PURPOSE The role of consolidation radiotherapy in patients with primary mediastinal B-cell lymphoma (PMBCL) is controversial. METHODS The IELSG37 trial, a randomized noninferiority study, aimed to assess whether irradiation can be omitted …
View article: Single gene mutations and prognosis in limited‐stage follicular lymphoma treated with radiation therapy
Single gene mutations and prognosis in limited‐stage follicular lymphoma treated with radiation therapy Open
Summary Radiotherapy is routinely used for management of limited‐stage follicular lymphoma (FL), yet half of patients ultimately relapse. We hypothesized that the presence of specific gene mutations may predict outcomes. We performed targe…
View article: WAVENUMBER FILTERING OF A RANDOM EXCITATION BY AN ELASTIC PLATE IMMERSED IN A FLUID
WAVENUMBER FILTERING OF A RANDOM EXCITATION BY AN ELASTIC PLATE IMMERSED IN A FLUID Open
View article: A Prospective Study of Machine Learning-Assisted Radiation Therapy Planning for Patients Receiving 54 Gy to the Brain
A Prospective Study of Machine Learning-Assisted Radiation Therapy Planning for Patients Receiving 54 Gy to the Brain Open
ML-assisted automated planning creates high-quality plans for patients with brain tumors, including children. Plans created with ML assistance delivered slightly less dose to normal brain tissues and can be designed in less time.
View article: Radiotherapy utilization and outcomes from a contemporary study of brentuximab vedotin with chemotherapy in pediatric high-risk Hodgkin lymphoma
Radiotherapy utilization and outcomes from a contemporary study of brentuximab vedotin with chemotherapy in pediatric high-risk Hodgkin lymphoma Open
View article: Radiation Therapy Technology Advances and Mitigation of Subsequent Neoplasms in Childhood Cancer Survivors
Radiation Therapy Technology Advances and Mitigation of Subsequent Neoplasms in Childhood Cancer Survivors Open
View article: Protocol for the ONLOOP trial: pragmatic randomized trial evaluating a province-wide system of personalized reminders for evidence-based surveillance tests in adult survivors of childhood cancer in Ontario
Protocol for the ONLOOP trial: pragmatic randomized trial evaluating a province-wide system of personalized reminders for evidence-based surveillance tests in adult survivors of childhood cancer in Ontario Open